Most cited papers in Pharmaceutical studies and practices
What are the most cited papers in Pharmaceutical studies and practices?
The most cited paper in Pharmaceutical studies and practices is "Arzneimittelforschung" (Barbara Miletzki, C. H. Gleiter, 2005), with 9,404 citations. Next come "Adherence to Medication" (8,018) and "Adherence to Long-Term Therapies: Evidence for Action" (6,332).
Showing 50 of 100 papers. Every paper with more than 644 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Arzneimittelforschung Barbara Miletzki, C. H. Gleiter · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz | Apr 2005 | 9,404 |
| 2 | Adherence to Medication Lars Osterberg, Terrence F. Blaschke · New England Journal of Medicine | 3 Aug 2005 | 8,018 |
| 3 | Adherence to Long-Term Therapies: Evidence for Action Sabina De Geest, Eduardo J. Sabate · European Journal of Cardiovascular Nursing | 5 Nov 2003 | 6,332 |
| 4 | SOME QUANTITATIVE USES OF DRUG ANTAGONISTS O. ARUNLAKSHANA, H. O. Schild · British Journal of Pharmacology and Chemotherapy | Mar 1959 | 3,967 |
| 5 | Arzneimittelforschung T.D. Bethke · Der Pneumologe | 24 Aug 2012 | 3,275 |
| 6 | Adverse drug reactions: definitions, diagnosis, and management Ivor Ralph Edwards, Jeffrey K Aronson · The Lancet | Oct 2000 | 3,019 |
| 7 | Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children Gregory L. Kearns, Susan M. Abdel‐Rahman, Sarah W. Alander et al. · New England Journal of Medicine | 17 Sep 2003 | 2,410 |
| 8 | Human ICE/CED-3 Protease Nomenclature Emad S. Alnemri, David J. Livingston, Donald W. Nicholson et al. · Cell | Oct 1996 | 2,392 |
| 9 | A Simple Estimate of Glomerular Filtration Rate in Children Derived From Body Length and Plasma Creatinine George J. Schwartz, George B. Haycock, Chester M. Edelmann et al. · PEDIATRICS | Aug 1976 | 2,391 |
| 10 | Rate of Release of Medicaments from Ointment Bases Containing Drugs in Suspension Takeru Higuchi · Journal of Pharmaceutical Sciences | Oct 1961 | 2,267 |
| 11 | Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness Robert Horne, John A Weinman · Journal of Psychosomatic Research | Dec 1999 | 2,213 |
| 12 | PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel Yong Zhang, Meirong Huo, Jianping Zhou et al. · Computer Methods and Programs in Biomedicine | 22 Feb 2010 | 2,091 |
| 13 | A new taxonomy for describing and defining adherence to medications Bernard Vrijens, Sabina De Geest, Dyfrig Arwyn Hughes et al. · British Journal of Clinical Pharmacology | 5 Apr 2012 | 2,053 |
| 14 | Under-Reporting of Adverse Drug Reactions Lorna Hazell, Saad Shakir · Drug Safety | 2006 | 1,950 |
| 15 | Can light absorption and photostability data be used to assess the photosafety risks in patients for a new drug molecule? Brian Henry, Christopher J. Foti, Karen M. Alsante · Journal of Photochemistry and Photobiology B Biology | 15 Apr 2009 | 1,942 |
| 16 | Effect of expectation and disconfirmation on postexposure product evaluations: An alternative interpretation. Richard L. Oliver · Journal of Applied Psychology | Aug 1977 | 1,669 |
| 17 | Reducing Inappropriate Polypharmacy Ian A Scott, Sarah Nicole Hilmer, Emily H. Reeve et al. · JAMA Internal Medicine | 23 Mar 2015 | 1,572 |
| 18 | Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis Samuele Cortese, Nicoletta Adamo, Cinzia Del Giovane et al. · The Lancet Psychiatry | 7 Aug 2018 | 1,410 |
| 19 | Solubilizing Excipients in Oral and Injectable Formulations Robert G. Strickley · Pharmaceutical Research | Feb 2004 | 1,404 |
| 20 | Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents Mark L. Wolraich, Joseph F. Hagan, Carla Allan et al. · PEDIATRICS | 30 Sep 2019 | 1,397 |
| 21 | Long-Term Effects of Budesonide or Nedocromil in Children with Asthma The Childhood Asthma Management Program Research Group · New England Journal of Medicine | 12 Oct 2000 | 1,375 |
| 22 | Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. Masashi Mukoyama, Kazuwa Nakao, Kiminori Hosoda et al. · Journal of Clinical Investigation | Apr 1991 | 1,363 |
| 23 | Determination of Tablet Strength by the Diametral-Compression Test John T. Fell, John M. Newton · Journal of Pharmaceutical Sciences | May 1970 | 1,336 |
| 24 | International Consensus Study of Antipsychotic Dosing David Martin Gardner, Andrea Lynn Murphy, Heather C. O’Donnell et al. · American Journal of Psychiatry | Apr 2010 | 1,324 |
| 25 | The assessment of refill compliance using pharmacy records: Methods, validity, and applications John F. Steiner, Allan V. Prochazka · Journal of Clinical Epidemiology | 1997 | 1,201 |
| 26 | The Global Burden of Asthma Sidney S. Braman · CHEST Journal | Jul 2006 | 1,187 |
| 27 | CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network MV Relling, Teri E. Klein · Clinical Pharmacology & Therapeutics | 26 Jan 2011 | 1,183 |
| 28 | Sex Differences in Pharmacokinetics and Pharmacodynamics Offie Porat Soldin, Donald R. Mattison · Clinical Pharmacokinetics | 2009 | 1,172 |
| 29 | Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies Philip N. Patsalos, David J. Berry, Blaise F. D. Bourgeois et al. · Epilepsia | 4 Apr 2008 | 1,154 |
| 30 | Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results Ulrike Ravens‐Sieberer, Monika Bullinger · Quality of Life Research | Jul 1998 | 1,130 |
| 31 | Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals Harriette G.C. Van Spall, Andrew Toren, ALEX J. KISS et al. · JAMA | 20 Mar 2007 | 1,075 |
| 32 | Nanosizing — Oral formulation development and biopharmaceutical evaluation Filippos Kesisoglou, Santipharp Panmai, Yunhui Wu · Advanced Drug Delivery Reviews | 26 May 2007 | 1,054 |
| 33 | Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents Christoph Ulrich Correll · JAMA | 27 Oct 2009 | 1,048 |
| 34 | Asthma: defining of the persistent adult phenotypes Sally E. Wenzel · The Lancet | Aug 2006 | 1,044 |
| 35 | The Impact of PEGylation on Biological Therapies Francesco Maria Veronese, Anna Mero · BioDrugs | 2008 | 1,041 |
| 36 | Trials to assess equivalence: the importance of rigorous methods: Fig 1 Byron C. Jones, Philip Jarvis, John A. Lewis et al. · BMJ | 6 Jul 1996 | 1,035 |
| 37 | THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES Arnold E. Reif, Joan M. Allen · The Journal of Experimental Medicine | Sep 1964 | 1,025 |
| 38 | The Methylation Effect in Medicinal Chemistry Eliezer J. Barreiro, Arthur Eugen Kümmerle, Carlos Alberto Manssour Fraga · Chemical Reviews | Jun 2011 | 1,023 |
| 39 | Pharmacogenetics: From Bench to Byte— An Update of Guidelines Jesse Joachim Swen, Marga Nijenhuis, Anthonius de Boer et al. · Clinical Pharmacology & Therapeutics | 16 Mar 2011 | 1,021 |
| 40 | Pharmaceutical applications of cyclodextrins: basic science and product development Þorsteinn Loftsson, Marcus Eli Brewster · Journal of Pharmacy and Pharmacology | 20 Jul 2010 | 1,021 |
| 41 | Timing of New Black Box Warnings and Withdrawals for Prescription Medications Karen E. Lasser · JAMA | May 2002 | 1,011 |
| 42 | Patient Medication Adherence: Measures in Daily Practice Benna Jimmy, Jimmy José · Oman Medical Journal | May 2011 | 987 |
| 43 | Review of the oral toxicity of polyvinyl alcohol (PVA) Christopher C. DeMerlis, D.R Schoneker · Food and Chemical Toxicology | 28 Dec 2002 | 937 |
| 44 | The Pharmacological Basis of Therapeutics, 7th ed John L. Egle · Journal of Pharmaceutical Sciences | Aug 1986 | 928 |
| 45 | Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs Eric Galia, Eleftheria Nicolaides, D. Hörter et al. · Pharmaceutical Research | May 1998 | 928 |
| 46 | Preventability and severity assessment in reporting adverse drug reactions Steven C. Hartwig, Jerry Siegel, Philip J. Schneider · American Journal of Health-System Pharmacy | Sep 1992 | 926 |
| 47 | Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation Tetsumi Irie, Kaneto Uekama · Journal of Pharmaceutical Sciences | Feb 1997 | 913 |
| 48 | Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice Kevin C. Farmer · Clinical Therapeutics | Jun 1999 | 904 |
| 49 | AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011 Christoph Hiemke et al. · Pharmacopsychiatry | Sep 2011 | 875 |
| 50 | Advances in Oral Drug Delivery Mohammed S. Alqahtani, Mohsin Kazi, Mohammad A. Alsenaidy et al. · Frontiers in Pharmacology | 19 Feb 2021 | 870 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.